Sign in

    Turner Hinrichs

    Research Analyst at Morgan Stanley

    Turner Hinrichs is a Research Analyst at Morgan Stanley specializing in equity research with coverage spanning companies such as Avient Corp and Westlake Corp. He has contributed actively to earnings calls and research initiatives, interrogating management teams of these covered firms and providing analytical insights. Hinrichs began his tenure at Morgan Stanley in New York and stands out for incisive company coverage, though specific investment performance metrics or third-party rankings are presently unavailable. He maintains professional credentials relevant to securities research; further details on regulatory registrations or licenses are not publicly confirmed.

    Turner Hinrichs's questions to AVIENT (AVNT) leadership

    Turner Hinrichs's questions to AVIENT (AVNT) leadership • Q2 2025

    Question

    Turner Hinrichs of Morgan Stanley, on for Vincent Andrews, questioned the durability of growth in key vectors like healthcare and defense. He also asked for the drivers of the SEM segment's year-over-year margin decline beyond the disclosed maintenance costs.

    Answer

    SVP & CFO Jamie Beggs affirmed the long-term growth potential in healthcare, citing underlying sub-markets like respiratory care, glucose monitoring, and drug delivery. For the SEM segment's Q2 margin, Beggs explained the decline was primarily due to the $3 million in planned maintenance and the flow-through of some higher-cost inventory. She guided for SEM margin expansion of approximately 100 basis points year-over-year in the second half of 2025.

    Ask Fintool Equity Research AI

    Turner Hinrichs's questions to WESTLAKE (WLK) leadership

    Turner Hinrichs's questions to WESTLAKE (WLK) leadership • Q1 2025

    Question

    Turner Hinrichs, on behalf of Vincent Andrews at Morgan Stanley, asked for clarification on the $100 million energy and feedstock headwind, questioning if it included one-time storm impacts. He also requested details on the $100 million CapEx reduction, including the level of maintenance spending and what was cut.

    Answer

    M. Bender, EVP and CFO, confirmed the headwind was entirely due to market dynamics in ethane, ethylene, and natural gas. He explained the CapEx reduction is partly linked to diminished spending at the epoxy operations in the Netherlands, for which a charge was taken in 2024. He noted ordinary maintenance runs $700-$800 million annually and that safety and reliability spending would not be reduced.

    Ask Fintool Equity Research AI

    Turner Hinrichs's questions to WESTLAKE (WLK) leadership • Q4 2024

    Question

    Turner Hinrichs, on for Vincent Andrews, asked about the relative priority of reducing Westlake's short ethylene position versus pursuing M&A in the HIP segment. He also inquired about the expected cash costs of the new cost savings plan.

    Answer

    EVP and CFO Steve Bender explained that acquiring ethylene is evaluated like any other business acquisition, with a focus on value. He mentioned debottlenecking the JV cracker as a possibility but noted cost estimates would need to be refreshed. Regarding the cost savings plan, Bender stated the cash outlay is minimal as the savings are primarily driven by negotiations, procurement, and general belt-tightening.

    Ask Fintool Equity Research AI